title: Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.
authors.forename: J A
authors.initials: JA
authors.lastname: Johnson
authors.forename: S H
authors.initials: SH
authors.lastname: Simpson
authors.forename: D T
authors.initials: DT
authors.lastname: Eurich
authors.forename: S R
authors.initials: SR
authors.lastname: Majumdar
mesh_terms: D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D050417:Insulin-Secreting Cells / Q000502:physiology*; D008687:Metformin / Q000627:therapeutic use; D012038:Regeneration; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D008687:Metformin